Costs of congenital rubella syndrome (CRS) in Oman: Evidence based on long-term follow-up of 43 children

Vaccine

Volumn 24, Issue 40-41, 2006, Pages 6437-6445

  Al Awaidy, Salah ^a   Griffiths, Ulla K ^b   Nwar, Hosammudin Mohammed ^a   Bawikar, Shyam ^a   Al Aisiri, Masoud Salim ^a   Khandekar, Rajiv ^c   Mohammad, Ali Jaffer ^a   Robertson, Susan E ^d  

^a MINISTRY OF HEALTH   (Oman)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Eye and Ear Health Care Muscat   (Oman)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Congenital rubella syndrome; Cost study; Disability

Indexed keywords

CARBAMAZEPINE; THYROXINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; CONGENITAL RUBELLA SYNDROME; COST OF ILLNESS; DISABILITY; EYE MALFORMATION; FOLLOW UP; HEALTH CARE COST; HEARING DISORDER; HUMAN; OMAN; PRIORITY JOURNAL; SPECIAL EDUCATION; SPEECH DISORDER;

CHILD; COSTS AND COST ANALYSIS; EYE DISEASES; FOLLOW-UP STUDIES; HEARING DISORDERS; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; NERVOUS SYSTEM DISEASES; OMAN; RUBELLA SYNDROME, CONGENITAL; RUBELLA VIRUS; SPEECH DISORDERS; TIME FACTORS;

EID: 33748458108     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.05.089     Document Type: Article

References (34)

1. Robertson S.E., Featherstone D.A., Gacic-Dobo M., and Hersh B.S. Rubella and congenital rubella syndrome: global update. Pan Am J Public Health 14 5 (2003) 306-315
2. Hinman A.R., Irons B., Lewis M., and Kandola K. Economic analyses of rubella and rubella vaccines: a global review. Bull World Health Org 80 4 (2002) 264-270
3. Kou U.K. More vaccines? Using economic analysis to decide. Bull World Health Org 80 4 (2002) 263
4. Juma A.H. Infantile "rubella" cataract in Oman. Oman Med Newsletter 6 1 (1989) 27-28
5. World Health Organization, Expanded Programme on Immunization. Rubella outbreak, Oman. Wkly Epidemiol Rec 69 45 (1994) 333-337
6. Kohler K.A., Suleiman A.J.M., Robertson S.E., Malankar P., Al-Khusaiby S., Helfand R.F., et al. Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial. J Infect Dis 187 Suppl. 1 (2003) S177-S185
7. Ministry of Health, Sultanate of Oman. Elimination of congenital rubella syndrome: progress towards the goal of elimination by 2005 in Oman. Commun Health Dis Surveil Newsletter 13 1 (2004) 1-4
8. Ministry of Health, Sultanate of Oman. Elimination of rubella and CRS in Oman by 2005. Commun Health Dis Surveil Newsletter 9 3 (2000) 1-3
9. Ministry of Education, Sultanate of Oman. Educational Statistical Yearbook, 35th issue, Academic Year 2004-2005 (2005), Ministry of Education, Muscat
10. OANDA. FXHistory: historical currency exchange rates. Accessed on 1 March 2005 at http://www.oanda.com/convert/fxhistory.
11. World Bank. World development indicators database. Accessed on 30 September 2005 at http://devdata.worldbank.org/data-query.
12. Pritchard C., and Schulpher M. Productivity costs: principles and practice in economic evaluation (2000), Office of Health Economics, London
13. Gold M.R., Siegel J.E., Russell L.B., and Weinstein M.C. Cost-effectiveness in health and medicine (1996), Oxford University Press, New York
14. United Nations Industrial Development Organization. Employment, wages and related indictors by industry. Accessed on 1 March 2005 at http://www.unido.org/data/country/stats.
15. Lanzieri T.M., Parise M.S., Siqueira M.M., Fortaleza B.M., Segatto T.C., and Prevots D.R. Incidence, clinical features and estimated costs of congenital rubella syndrome after a large rubella outbreak in Recife, Brazil, 1999-2000. Pediatr Infect Dis J 23 12 (2004) 1116-1122
16. Kommu R., and Chase H. Follow-up of rubella issues and costing of CRS in Barbados. Final report, 14th meeting of the English-speaking Caribbean EPI managers. Castries, Saint Lucia, 18-20 November 1997 (1998), Pan American Health Organization, Washington, DC
17. Kandola K. CRS cost burden analysis for Guyana. Final report, 14th meeting of the English-speaking Caribbean EPI managers. Castries, Saint Lucia, 18-20 November 1997 (1998), Pan American Health Organization, Washington, DC
18. Robinson M. CRS unit costing in Jamaica. Final Report, 14th meeting of the English-speaking Caribbean EPI managers. Castries, Saint Lucia, 18-20 November 1997 (1998), Pan American Health Organization, Washington, DC
19. Saad de Owens C., and Tristan de Espino R. Rubella in Panama: still a problem. Pediatr Infect Dis J 8 (1989) 110-115
20. World Health Organization. Immunization schedule by antigen. Accessed on 15 November 2005 at http://www.who.int/immunization_monitoring/en/globalsummary/schedulesele ct.cfm.
21. World Health Organization. Rubella vaccines: WHO position paper. Wkly Epidemiol Rec 75 20 (2000) 181-189
22. Menser M.A., Dods L., and Harley J.D. A twenty-five year follow-up of congenital rubella. Lancet ii (1967) 1347-1350
23. McIntosh E.D.G., and Menser M.A. A fifty-year follow-up of congenital rubella. Lancet 340 (1992) 414-415
24. Forrest J.M., Turnbull F.M., Sholler G.F., Hawker R.E., Martin F.J., Doran T.T., et al. Gregg's congenital rubella patients 60 years later. Med J Aust 177 11-12 (2002) 664-667
25. Munroe S. A survey of late emerging manifestations of congenital rubella in Canada (1999), Canadian Deafblind and Rubella Association, Brantford, Ontario
26. Tookey P.A., and Peckham C.S. Surveillance of congenital rubella in Great Britain, 1971-96. BMJ 318 (1999) 769-770
27. Khandekar R., Al-Awaidy S., Ganesh A., and Bawikar S. An epidemiological and clinical study of ocular manifestations of congenital rubella syndrome in Omani children. Arch Ophthalmol 122 4 (2004) 541-544
28. Cooper L.Z., Green R.H., Krugman S., Giles J.P., and Mirick G.S. Neonatal thrombocytopenic purpura and other manifestations of rubella contracted in utero. Am J Dis Child 110 (1965) 416-427
29. Modlin J.F., and Brandling Bennett A.D. Surveillance of congenital rubella syndrome 1969-1973. J Infect Dis 130 3 (1974) 316-318
30. O'Neill J.F. The ocular manifestations of congenital infection: a study of the early effect and long-term outcome of maternally transmitted rubella and toxoplasmosis. Tr Am Ophth Soc 96 (1998) 813-879
31. Wolff S.M. The ocular manifestations of congenital rubella: a prospective study of 328 cases of congenital rubella. J Pediatr Ophthalmol 10 2 (1973) 101-141
32. Ramsden R.T. Prognosis after cochlear implantation. BMJ 328 (2004) 419-420
33. Kahndekar R., and Al-Khabori M. Double disability: the hearing-impaired blind in the Sultanate of Oman. Int J Audiol 43 (2004) 1-5
34. Coucouvanis K., Prouty R.W., Bruininks R.H., and Lakin K.C. Current populations and longitudinal trends of state residential settings (1950-2004). In: Prouty R.W., Smith G., and Lakin K.C. (Eds). Residential services for persons with developmental disabilities: status and trends through 2004 (2005), University of Minnesota, Research and Training Center on Community Living, Institute on Community Integration, Minneapolis